July 09, 2020
According to the research report titled ‘United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026’, available with Market Study Report LLC, United States vaccines market is expected to garner revenues worth USD 26 billion by the year 2026.
The ‘United States vaccines market’ report offers crucial information regarding this expanding and fast-evolving industry vertical. It provides significant information regarding the current trends as well as the growth prospects in the market space. Additionally, it offers historical data of United States vaccines market between the years 2015 and 2018 as well as predictions for the period of 2019-2026.
The document scrutinizes the United States vaccines market on the basis of current trends, demand, size, revenues while providing estimations for the same through 2026. Additionally, it delivers vital data regarding the current and future developments of the said market.
The study comprises of crucial insights regarding 27 leading vaccines in the overall market. Market share of each leading vaccine, regulatory outlook and its respective pricing patterns are analyzed in the document.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2333429/
The 27 leading vaccines in United States market are TDVAX, HEPLISAV-B, Pediarix/Infanrix, Rotarix, Rotateq, Recombivax HB, Pentacel, Shingrix, Trumenba, Menveo, Bexsero, Boostrix, Adacel, M-M-R II, Havrix/Twinrix/Engerix-B, Flaurix/FluLaval, Pneumovax 23, Proquad, Menactra, Varivax, Fluad, Afluria Quadrivalent, Flucelvax Quadrivalent, Flublok, Fluzone, Gardasil/Gardasil 9 and Prevnar/Prevnar 13.
Information regarding business-centric activities such as licensing agreements, distribution, mergers & acquisitions, partnerships and collaborations is presented in the document. The study also analyzes the factors that are positively as well as negatively impacting the overall market outlook over the estimated timeframe.
Lastly, the report entails the business profiles of various companies operating in United States vaccines market. The key participants are Dynavax Technologies Corporation, GlaxoSmithKline plc, Grifols S.A., Sanofi Pasteur, Merck & Co. Inc. and Pfizer Inc. among others. Details regarding recent developments, vaccines portfolio and other products in pipeline of each industry colossus are entailed.